By Erin Marie Daly ( July 14, 2009, 12:00 AM EDT) -- A federal judge has thrown out a putative class action accusing Schering-Plough Corp. of causing economic losses to a group of health and welfare funds, third-party payors, and individual consumers by illegally marketing its drugs Intron-A and Temodar for off-label uses, ruling that the plaintiffs failed to prove their theories of injury....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.